Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
In vivo exploration of activated microglia in neurodegenerative diseases is achievable by Positron Emission Tomography (PET) imaging, using dedicated radiopharmaceuticals targeting the translocator protein-18 kDa (TSPO). In this review, we emphasized the major advances made over the last 20 years, thanks to TSPO PET imaging, to define the pathophysiological implication of microglia activation and neuroinflammation in neurodegenerative diseases, including Parkinson’s disease, Huntington’s disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, and also in psychiatric disorders. The extent and upregulation of TSPO as a molecular biomarker of activated microglia in the human brain is now widely documented in these pathologies, but its significance, and especially its protective or deleterious action regarding the disease’s stage, remains under debate. Thus, we exposed new and plausible suggestions to enhance the contribution of TSPO PET imaging for biomedical research by exploring microglia’s role and interactions with other cells in brain parenchyma. Multiplex approaches, associating TSPO PET radiopharmaceuticals with other biomarkers (PET imaging of cellular metabolism, neurotransmission or abnormal protein aggregates, but also other imaging modalities, and peripheral cytokine levels measurement and/or metabolomics analysis) was considered. Finally, the actual clinical impact of TSPO PET imaging as a routine biomarker of neuroinflammation was put into perspective regarding the current development of diagnostic and therapeutic strategies for neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The translocator protein, a hallmark of activated microglia, serves as the gold standard for PET-based neuroinflammation imaging [57].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Methods to image microglia exist and are being used to test the effect of treatments on microglia205–210.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Giannetti, P., Politis, M., Su, P., Turkheimer, F., Malik, O., Keihaninejad, S., Wu, K., Reynolds, R., Nicholas, R., & Piccini, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.018 · Cited by 86
Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders
Shen, L.-H., Liao, M.-H., & Tseng, Y.-C. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/259349 · Cited by 86
Marlatt, M. W., Bauer, J., Aronica, E., van Haastert, E. S., Hoozemans, J. J. M., Joels, M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/693851 · Cited by 83 · cited 1×
“Aβ (both, soluble [120] and fibrillary [121]) can bind to several Toll-like receptors (TLR) and co-receptors expressed on microglia, leading to its activation [122] and promoting the formation of clusters of activated microglia surrounding amyloid plaques in AD brains [123].”
BackgroundMitochondria in activated microglia in vitro
Banati, R. B., Egensperger, R., Maaßen, A., Hager, G., Kreutzberg, G. W., Manuel, B. R., & Graeber, M. B. (2004) · Journal of Neurocytology · doi:10.1007/s11068-004-0515-7 · Cited by 82 · cited 2×
“As a result, this increased density of TSPO in CNS diseases has been considered to be a relevant and an early biomarker to evaluate neuroinflammation over disease progression [33].”
BackgroundVarrone, A., Oikonen, V., Forsberg, A., Joutsa, J., Takano, A., Solin, O., Haaparanta-Solin, M., Nag, S., Nakao, R., Al-Tawil, N., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2955-8 · Cited by 79
Zinnhardt, B., Viel, T., Wachsmuth, L., Vrachimis, A., Wagner, S., Breyholz, H., Faust, A., Hermann, S., Kopka, K., Faber, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.149 · Cited by 76
Ishizawa, K., Komori, T., Arai, N., Mizutani, T., & Hirose, T. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2007.00855.x · Cited by 76 · cited 1×
“Remarkably, the analysis of histopathological patterns of MSA brains revealed that the amount of GCIs and the level of microglial activity is reduced especially since the tissue injury becomes severe in white matter areas, unlike gray matter areas [69].”
BackgroundEnergy defects in Huntington's disease: Why “in vivo” evidence matters
Liot, G., Valette, J., Pépin, J., Flament, J., & Brouillet, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.065 · Cited by 76 · cited 1×
“, abnormal protein-protein interaction, promoting pro-inflammatory cytokines) [79,80].”
Delayed inflammatory mRNA and protein expression after spinal cord injury
Byrnes, K. R., Washington, P. M., Knoblach, S. M., Hoffman, E., & Faden, A. I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-130 · Cited by 75
Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106
Takano, A., Piehl, F., Hillert, J., Varrone, A., Nag, S., Gulyás, B., Stenkrona, P., Villemagne, V. L., Rowe, C. C., Macdonell, R., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-30 · Cited by 74
Multiple system atrophy: pathogenic mechanisms and biomarkers
Jellinger, K. A., & Wenning, G. K. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1545-2 · Cited by 73 · cited 1×
“In contrast to PD, the accumulation of α-synuclein fibrils leads to the generation of glial cytoplasmic inclusions (GCI) which affects mostly the oligodendroglia rather than neurons [59].”
BackgroundRadioisotopic Imaging of Neuroinflammation: FIGURE 1.
Winkeler, A., Boisgard, R., Martin, A., & Tavitian, B. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065680 · Cited by 69 · cited 1×
“Furthermore, cells of the mononuclear phagocyte lineage, such as peripheral macrophages, also express the TSPO and, in the case of a disrupted BBB, also infiltrate the damaged CNS due to the vascular permeability increased by neuroinflammation [20].”
BackgroundMehrabi, N. F., Waldvogel, H. J., Tippett, L. J., Hogg, V. M., Synek, B. J., & Faull, R. L. M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.015 · Cited by 69 · cited 1×
“to lesion topology, which even depends on the stage of HD, symptoms include motor troubles (chorea, parkinsonism), cognitive decline (slowed mentation, impaired strategy) and psychiatric disorders (mood, irritability, apathy, depression) [77,90].”
BackgroundBorgonovo, J. E., Allende-Castro, C., Laliena, A., Guerrero, N., Hernán Silva, I., & Concha, M. L. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.11.009 · Cited by 68
TSPO is a REDOX regulator of cell mitophagy
Gatliff, J., & Campanella, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150037 · Cited by 65 · cited 2×
“Subsequently, this ROS generation leads to an accumulation of defective mitochondria due to an ineffective mitophagy PARK2-dependent mitochondriopathy [24], which is involved in several neurodegenerative diseases such as Parkinson’s disease (PD) [25], Huntington’s disease (HD) [26] and Alzheimer‘s disease (AD) [27].”
BackgroundTranslocator protein (18 kDa) is involved in the regulation of reactive gliosis
Veiga, S., Carrero, P., Pernia, O., Azcoitia, I., & Garcia‐Segura, L. M. (2007) · Glia · doi:10.1002/glia.20558 · Cited by 62 · cited 2×
“The use of TSPO ligands in rodent models of neuroinflammation (e.g., kainic acid excitoxicity [29] or intracerebroventricular infusion of lipopolysaccharide (LPS) [30]) highlighted TSPO’s involvement in hippocampal gliosis and especially in microgliosis.”
BackgroundContinuous prediction of secondary progression in the individual course of multiple sclerosis
Skoog, B., Tedeholm, H., Runmarker, B., Odén, A., & Andersen, O. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.04.004 · Cited by 60
Lyck, L., Dalmau, I., Pakkenberg, B., Chemnitz, J., Schrøder, H. D., Finsen, B. R., & Gundersen, H. J. G. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.06.003 · Cited by 55 · cited 1×
“Microglia represent approximately 5–15% of all cells in the human brain [1,2].”
BackgroundHeterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications
Kooi, E.-J., Strijbis, E. M. M., van der Valk, P., & Geurts, J. J. G. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b1c · Cited by 55
Review: Multiple system atrophy: emerging targets for interventional therapies
Stefanova, N., & Wenning, G. K. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12304 · Cited by 54 · cited 1×
“In MSA, these results appear to echo the findings of neuropathological studies and could reflect the demyelination process which predominantly affects the MSA-C variant [67].”
ResultTang, D., McKinley, E. T., Hight, M. R., Uddin, M. I., Harp, J. M., Fu, A., Nickels, M. L., Buck, J. R., & Manning, H. C. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4001874 · Cited by 53
Martín, A., Szczupak, B., Gómez‐Vallejo, V., Domercq, M., Cano, A., Padró, D., Muñoz, C., Higuchi, M., Matute, C., & Llop, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3670-14.2015 · Cited by 52
Pupillo, G., Boschi, A., Martini, P., Uccelli, L., Pasquali, M., Duatti, A., Domenico, G. D., Giganti, M., Taibi, A., Gambaccini, M., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3198-z · Cited by 52
Lee, J. C., Seong, J., Kim, S. H., Lee, S. J., Cho, Y. J., An, J., Nam, D., Joo, K. M., & Ik, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.026 · Cited by 51
Domercq, M., Szczupak, B., Gejo, J., Gómez‐Vallejo, V., Padró, D., Gona, K. B., Dollé, F., Higuchi, M., Matute, C., Llop, J., et al. (2016) · Theranostics · doi:10.7150/thno.15616 · Cited by 50
New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
Park, H. K., & Chung, S. J. (2013) · Journal of Movement Disorders · doi:10.14802/jmd.13001 · Cited by 49
Volk, D. W. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.019 · Cited by 47
Arbo, B. D., Benetti, F., García‐Segura, L. M., & Ribeiro, M. F. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 46
PET imaging in multiple sclerosis
Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 45
Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration
Henkel, K., Karitzky, J., Schmid, M., Mader, I., Glatting, G., Unger, J. W., Neumaier, B., Ludolph, A. C., Reske, S. N., & Landwehrmeyer, G. B. (2004) · Movement Disorders · doi:10.1002/mds.20040 · Cited by 45
Glial Pathology in Bipolar Disorder: Potential Therapeutic Implications
Dong, X., & Zhen, X. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12390 · Cited by 41
The Role of Dopamine and Dopaminergic Pathways in Dystonia: Insights from Neuroimaging
Karimi, M., & Perlmutter, J. S. (2015) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.267 · Cited by 39
Datta, G., Violante, I. R., Scott, G., Zimmerman, K., Santos-Ribeiro, A., Rabiner, E. A., Gunn, R. N., Malik, O., Ciccarelli, O., Nicholas, R., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516681504 · Cited by 36
de Tassigny, A. D., Assaly, R., Schaller, S., Pruss, R. M., Berdeaux, A., & Morin, D. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.10.001 · Cited by 35 · cited 1×
“Most studies point out that high TSPO expression attenuates ROS generation [22,23].”
BackgroundKumakura, Y., Danielsen, E. H., Reilhac, A., Gjedde, A., & Cumming, P. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00299.x · Cited by 30
Zivadinov, R., & Pirko, I. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-9 · Cited by 29
Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes
Kobylecki, C., Counsell, S. J., Cabanel, N., Wächter, T., Turkheimer, F., Eggert, K. M., Oertel, W. H., Brooks, D. J., & Gerhard, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.017 · Cited by 26 · cited 3×
“…vs. HC 11C-PK11195 Pons tracer BPND in PD group greater than in the control group No significant difference in thalamus, striatum or midbrain binding Kobylecki et al. (2013) [61] 8 PD patients without dementia vs. 10 HC 11C-PK11195 BPND significant increase in temporal, parietal and occipital…”
BackgroundAging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector
Zhao, W., Zhang, J., Davis, E. G., & Rebeck, G. W. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00210 · Cited by 25 · cited 1×
“This Aβ-induced inflammatory environment [126], combined with effect of immunosenescence on microglia [127,128], lead to a situation in which microglia that initially exhibited a neuroprotective M2 phenotype at the beginning of AD [129], become confined to a classical activated state (i.”
BackgroundIn vivo imaging of system xc- as a novel approach to monitor multiple sclerosis
Martín, A., Vázquez‐Villoldo, N., Gómez‐Vallejo, V., Padró, D., Soria, F. N., Szczupak, B., Plaza‐García, S., Arrieta, A., Reese, T., Llop, J., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3275-3 · Cited by 25
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders
Slifstein, M., & Abi‐Dargham, A. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.002 · Cited by 25
The Role of Dopamine and Dopaminergic Pathways in Dystonia: Insights from Neuroimaging
Karimi, M., & Perlmutter, J. S. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8j101xv · Cited by 22
Reliability of measuring regional callosal atrophy in neurodegenerative diseases
Schependom, J. V., Jain, S., Cambron, M., Vanbinst, A., Mey, J. D., Smeets, D., & Nagels, G. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.10.012 · Cited by 19
Magnetic resonance imaging of glutamate in neuroinflammation
Chen, Y., Dai, Z., Shen, Z., Lin, G., Zhuang, C., Li, H. J., & Wu, R. (2016) · Radiology of Infectious Diseases · doi:10.1016/j.jrid.2016.03.006 · Cited by 16
Tarkkonen, A., Rissanen, E., Tuokkola, T., & Airas, L. M. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.07.016 · Cited by 16
Schou, M., Varnäs, K., Sandell, J., Johnström, P., Cselényi, Z., Svensson, S., Nakao, R., Amini, N., Bergman, L. B., Sumic, A., et al. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0666-3 · Cited by 14
Bray, N., Burrows, F., Jones, M., Berwick, J., Allan, S. M., & Schießl, I. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0664-x · Cited by 10
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis
Gupta, S., Utoft, R., Hasseldam, H., Schmidt-Christensen, A., Hannibal, T. D., Hansen, L., Fransén-Pettersson, N., Agarwal-Gupta, N., Rozell, B., Andersson, Å., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076330 · Cited by 7
Cited by
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Global brain inflammation in stroke
Shi, K., Tian, D.-C., Li, Z.-G., Ducruet, A. F., Lawton, M. T., & Shi, F.-D. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30078-x · Cited by 911
La Joie, R., Visani, A. V., Baker, S. L., Brown, J. A., Bourakova, V., Cha, J., Chaudhary, K., Edwards, L., Iaccarino, L., Janabi, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5732 · Cited by 612
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 379
Microglia in multiple sclerosis: Friend or foe
Guerrero, B. L., & Sicotte, N. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00374 · Cited by 215
“Translocator Protein (TSPO) is located in the outer mitochondrial membrane and is upregulated in activated microglia (46, 47).”
BackgroundInfluential
Metadata
- Authors
- Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- CHRU Tours, 2 Boulevard Tonnellé, 37044 Tours, France
- Corresponding author
- Dupont, Anne-Claire
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-04-07
- Volume
- 18
- Issue
- 4
- Pages
- 785
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5412369
- OpenAlex
- W2605220880
- Cited by
- 182
- References
- 249
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 14 · 2021: 13 · 2020: 34 · 2019: 31 · 2018: 25 · 2017: 13
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0018)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- translocator protein (TSPO), TSPO PET imaging, microglial activation, neuroinflammation, neurodegenerative diseases, Parkinson's disease, Huntington's disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, mental illness, molecular biomarkers, radiopharmaceuticals, multiplexed imaging, cytokines, metabolomics
- MeSH terms
- Humans, Biomarkers, Up-Regulation, Microglia, Receptors, GABA, Radiopharmaceuticals, Neurodegenerative Diseases, Early Diagnosis, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.